Efficacy, safety and tolerability of rozanolixizumab in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a randomised, subject-blind, investigator-blind, placebo-controlled, phase 2a trial and open-label extension study

罗扎诺利珠单抗对慢性炎症性脱髓鞘性多发性神经根神经病患者的疗效、安全性和耐受性：一项随机、受试者盲法、研究者盲法、安慰剂对照、 2a 期试验和开放标签扩展研究